Sorrento Therapeutics Inc
OTC:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
OTC:SRNE
Watchlist
Price: 0.0032 USD 18.52% Market Closed
Market Cap: 1.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of SRNE.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SRNE Intrinsic Value
Not Available
Base Case Scenario
Compare SRNE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SRNE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sorrento Therapeutics Inc

Current Assets 133.1m
Cash & Short-Term Investments 80.6m
Receivables 32.7m
Other Current Assets 19.8m
Non-Current Assets 323.6m
Long-Term Investments 12m
PP&E 106.6m
Intangibles 202.6m
Other Non-Current Assets 2.4m
Current Liabilities 264.9m
Accounts Payable 18.6m
Accrued Liabilities 111.9m
Other Current Liabilities 134.4m
Non-Current Liabilities 396.9m
Long-Term Debt 21.7m
Other Non-Current Liabilities 375.2m
Efficiency

Free Cash Flow Analysis
Sorrento Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sorrento Therapeutics Inc

Revenue
64.3m USD
Cost of Revenue
-35.6m USD
Gross Profit
28.7m USD
Operating Expenses
-378.8m USD
Operating Income
-350.1m USD
Other Expenses
-197.9m USD
Net Income
-548m USD
Fundamental Scores

SRNE Profitability Score
Profitability Due Diligence

Sorrento Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

28/100
Profitability
Score

Sorrento Therapeutics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

SRNE Solvency Score
Solvency Due Diligence

Sorrento Therapeutics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
36/100
Solvency
Score

Sorrento Therapeutics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SRNE Price Targets Summary
Sorrento Therapeutics Inc

There are no price targets for SRNE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Sorrento Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SRNE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SRNE Insider Trading
Buy and sell transactions by insiders